These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 18950446

  • 1. Combination therapy with flupirtine and opioid: studies in rat pain models.
    Goodchild CS, Kolosov A, Tucker AP, Cooke I.
    Pain Med; 2008 Oct; 9(7):928-38. PubMed ID: 18950446
    [Abstract] [Full Text] [Related]

  • 2. Combination therapy with flupirtine and opioid: open-label case series in the treatment of neuropathic pain associated with cancer.
    Goodchild CS, Nelson J, Cooke I, Ashby M, Jackson K.
    Pain Med; 2008 Oct; 9(7):939-49. PubMed ID: 18950447
    [Abstract] [Full Text] [Related]

  • 3. Flupirtine enhances the anti-hyperalgesic effects of morphine in a rat model of prostate bone metastasis.
    Kolosov A, Goodchild CS, Williams ED, Cooke I.
    Pain Med; 2012 Nov; 13(11):1444-56. PubMed ID: 23078152
    [Abstract] [Full Text] [Related]

  • 4. Flupirtine antinociception in the rat orofacial formalin test: an analysis of combination therapies with morphine and tramadol.
    Capuano A, De Corato A, Treglia M, Tringali G, Navarra P.
    Pharmacol Biochem Behav; 2011 Jan; 97(3):544-50. PubMed ID: 21073890
    [Abstract] [Full Text] [Related]

  • 5. Studies of synergy between morphine and a novel sodium channel blocker, CNSB002, in rat models of inflammatory and neuropathic pain.
    Kolosov A, Goodchild CS, Cooke I.
    Pain Med; 2010 Jan; 11(1):106-18. PubMed ID: 20447294
    [Abstract] [Full Text] [Related]

  • 6. Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain.
    Christoph T, De Vry J, Tzschentke TM.
    Neurosci Lett; 2010 Feb 12; 470(2):91-4. PubMed ID: 20026182
    [Abstract] [Full Text] [Related]

  • 7. Intravenous injection of leconotide, an omega conotoxin: synergistic antihyperalgesic effects with morphine in a rat model of bone cancer pain.
    Kolosov A, Aurini L, Williams ED, Cooke I, Goodchild CS.
    Pain Med; 2011 Jun 12; 12(6):923-41. PubMed ID: 21539704
    [Abstract] [Full Text] [Related]

  • 8. Influence of low doses of naltrexone on morphine antinociception and morphine tolerance in male and female rats of four strains.
    Terner JM, Barrett AC, Lomas LM, Negus SS, Picker MJ.
    Pain; 2006 May 12; 122(1-2):90-101. PubMed ID: 16527399
    [Abstract] [Full Text] [Related]

  • 9. The antinociceptive activity of flupirtine: a structurally new analgesic.
    Nickel B.
    Postgrad Med J; 1987 May 12; 63 Suppl 3():19-28. PubMed ID: 2833734
    [Abstract] [Full Text] [Related]

  • 10. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
    Williams J, Haller VL, Stevens DL, Welch SP.
    Eur J Pharmacol; 2008 Apr 14; 584(1):78-86. PubMed ID: 18313663
    [Abstract] [Full Text] [Related]

  • 11. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
    Hernández-Delgadillo GP, Cruz SL.
    Eur J Pharmacol; 2006 Sep 28; 546(1-3):54-9. PubMed ID: 16914138
    [Abstract] [Full Text] [Related]

  • 12. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
    Al-Khrasani M, Spetea M, Friedmann T, Riba P, Király K, Schmidhammer H, Furst S.
    Brain Res Bull; 2007 Oct 19; 74(5):369-75. PubMed ID: 17845912
    [Abstract] [Full Text] [Related]

  • 13. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
    Obara I, Makuch W, Spetea M, Schütz J, Schmidhammer H, Przewlocki R, Przewlocka B.
    Eur J Pharmacol; 2007 Mar 08; 558(1-3):60-7. PubMed ID: 17204264
    [Abstract] [Full Text] [Related]

  • 14. The novel inhibitor of the heterotrimeric G-protein complex, BIM-46187, elicits anti-hyperalgesic properties and synergizes with morphine.
    Favre-Guilmard C, Zeroual-Hider H, Soulard C, Touvay C, Chabrier PE, Prevost G, Auguet M.
    Eur J Pharmacol; 2008 Oct 10; 594(1-3):70-6. PubMed ID: 18664366
    [Abstract] [Full Text] [Related]

  • 15. CNSB004 (Leconotide) causes antihyperalgesia without side effects when given intravenously: a comparison with ziconotide in a rat model of diabetic neuropathic pain.
    Kolosov A, Goodchild CS, Cooke I.
    Pain Med; 2010 Feb 10; 11(2):262-73. PubMed ID: 20002322
    [Abstract] [Full Text] [Related]

  • 16. Intrathecal co-administration of morphine and nimodipine produces higher antinociceptive effect by synergistic interaction as evident by injecting different doses of each drug in rats.
    Gupta H, Verma D, Ahuja RK, Srivastava DN, Wadhwa S, Ray SB.
    Eur J Pharmacol; 2007 Apr 30; 561(1-3):46-53. PubMed ID: 17320072
    [Abstract] [Full Text] [Related]

  • 17. Epidural ketamine potentiates epidural morphine but not fentanyl in acute nociception in rats.
    Hoffmann VL, Baker AK, Vercauteren MP, Adriaensen HF, Meert TF.
    Eur J Pain; 2003 Apr 30; 7(2):121-30. PubMed ID: 12600793
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Antihyperalgesic and Opioid-Sparing Effects of 5-Day Ketamine and Morphine Infusion ("Burst Ketamine") in Diabetic Neuropathic Rats.
    Mak P, Broadbear JH, Kolosov A, Goodchild CS.
    Pain Med; 2015 Sep 30; 16(9):1781-93. PubMed ID: 25800174
    [Abstract] [Full Text] [Related]

  • 19. Nefopam and ketoprofen synergy in rodent models of antinociception.
    Girard P, Verniers D, Coppé MC, Pansart Y, Gillardin JM.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):263-71. PubMed ID: 18316069
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of antinociception by co-administration of ibuprofen and caffeine in arthritic rats.
    López JR, Domínguez-Ramírez AM, Cook HJ, Bravo G, Díaz-Reval MI, Déciga-Campos M, López-Muñoz FJ.
    Eur J Pharmacol; 2006 Aug 21; 544(1-3):31-8. PubMed ID: 16872598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.